Company Hangzhou AGS MedTech Co., Ltd.

Equities

688581

CNE100005ZF0

Advanced Medical Equipment & Technology

Analysts' Consensus

Business Summary

Sales per Business

Sales per region

Managers

Members of the board

Share class

Shareholders

Company contact information

Sector

Sales per Business

Sales per region

Ratings for Hangzhou AGS MedTech Co., Ltd.

EPS Revisions

Annual profits - Rate of surprise

Sector Other Advanced Medical Equipment & Technology

End-of-day quote Shanghai S.E. Other stock markets 06:00:00 2024-05-07 pm EDT			5-day change	1st Jan Change
84.73 ^CNY	-3.57%		+1.03%	-32.11%

Apr. 22	Hangzhou AGS MedTech Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
Apr. 02	Tranche Update on Hangzhou AGS MedTech Co., Ltd.'s Equity Buyback Plan announced on February 8, 2024.	CI

Hangzhou AGS MedTech Co Ltd is a China-based company mainly engaged in the research, development, production and sales of endoscopic minimally invasive diagnostic and therapeutic devices. The Company's main products are used in the field of digestive endoscopy diagnosis and treatment, and are divided into hemostatic closure, EMR/ESD, biopsy, ERCP and diagnosis and treatment instruments according to their therapeutic purposes. The hemostatic closure category includes clip devices and single-use bipolar high-frequency hemostats. Medical instruments include high-frequency surgical equipment, carbon dioxide gas supply devices for endoscopes, and water supply devices for endoscopes. The biopsy category includes single-use biopsy forceps and single-use graspers.

Number of employees: 592

CNY in Million	2022	Weight	2023	Weight	Delta
GI Category 66.0 %	-	-	336	66.0 %	-
Endoscopic Mucosal Resection/Endoscopic Submucosal Dissection 20.6 %	69	18.8 %	105	20.6 %	+51.38%
Endoscopic Retrograde Cholangiopancreatography 7.5 %	29	8.0 %	38	7.5 %	+29.22%
Diagnostic and Therapeutic Instruments 5.4 %	20	5.4 %	28	5.4 %	+38.96%
Other Business 0.5 %	-	-	3	0.5 %	-

CNY in Million	2022	Weight	2023	Weight	Delta
China 51.9 %	190	51.5 %	264	51.9 %	+38.96%
Overseas 48.1 %	179	48.5 %	245	48.1 %	+36.79%

Managers	Title	Age	Since
Cheng Zhang CEO	Chief Executive Officer	54	11-11-30
Jun Can Chen DFI	Director of Finance/CFO	43	17-12-31
Bai Ming Shi CHM	Chairman	45	11-12-31
Yue Yuan Sheng BRD	Director/Board Member	47	11-12-31
Chun Qi Han BRD	Director/Board Member	41	11-12-31
Meng Xin Wei IRC	Investor Relations Contact	-	-
Qin Hua Zhang SEC	Corporate Secretary	44	11-12-31

Members of the board	Title	Age	Since
Jian Hai Wu BRD	Director/Board Member	44	19-05-28
Li An Xia BRD	Director/Board Member	60	19-05-28
Cheng Zhang CEO	Chief Executive Officer	54	11-11-30
Chun Qi Han BRD	Director/Board Member	41	11-12-31
Yue Yuan Sheng BRD	Director/Board Member	47	11-12-31
Bai Ming Shi CHM	Chairman	45	11-12-31
Jin Feng Li BRD	Director/Board Member	40	23-08-30

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	1	57,870,971	13,360,625 ( 23.09 %)	260,398 ( 0.4500 %)	23.09 %

Name	Equities	%	Valuation
Penghua Fund Management Co., Ltd. 6.594 %	851,893	6.594 %	9 M ¥
Bosera Asset Management Co., Ltd. 5.150 %	665,411	5.150 %	7 M ¥
Huashang Fund Management Co., Ltd. 3.904 %	504,392	3.904 %	5 M ¥
JPMorgan Asset Management (China) Co Ltd. 3.114 %	402,289	3.114 %	4 M ¥
Fullgoal Fund Management Co., Ltd. 2.402 %	310,342	2.402 %	3 M ¥
China Southern Asset Management Co., Ltd. 2.255 %	291,338	2.255 %	3 M ¥
Great Wall Fund Management Co., Ltd. 1.994 %	257,661	1.994 %	3 M ¥
Rongtong Fund Management Co., Ltd. 1.984 %	256,313	1.984 %	3 M ¥
Wanjia Asset Management Co., Ltd. 1.582 %	204,363	1.582 %	2 M ¥
Purekind Fund Management Co., Ltd. 1.361 %	175,815	1.361 %	2 M ¥

Name	Equities	%	Valuation
Hangzhou Yijia Investment Management Co. Ltd. 43.02 %	18,892,898	43.02 %	196 M ¥
Daan Gene Technology Co. Ltd. 13.66 %	6,000,000	13.66 %	62 M ¥
Cheng Zhang 9.410 %	4,131,963	9.410 %	43 M ¥
Dingjie Ningbo 7.560 %	3,319,998	7.560 %	34 M ¥
Suzhou Indl Park State-Owned Cap Invt & Operation Hldg Co. Ltd 6.589 %	2,893,311	6.589 %	30 M ¥
Zhejiang Silicon Paradise Asset Management Group Co. Ltd. 5.930 %	2,604,058	5.930 %	27 M ¥
Guangzhou Daan Jinghan Investment Consulting Co. Ltd. 5.897 %	2,589,639	5.897 %	27 M ¥
Ningbo Jiayi Investment Management Partnership 4.359 %	1,913,983	4.359 %	20 M ¥
Daohe Ningbo 2.403 %	1,055,121	2.403 %	11 M ¥

Hangzhou AGS MedTech Co., Ltd.

Bldg 5&6, 597 Kangxin Road Yuhang District

31110, Hangzhou

http://www.bioags.com

address Hangzhou AGS MedTech Co., Ltd.(688581)

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

84.73 CNY

Average target price

122.5 CNY

Spread / Average Target

+44.58%

Consensus

Estimates Revisions

Company calendar

Healthcare

Healthcare Services

Healthcare Equipment & Supplies

Advanced Medical Equipment & Technology

Other Advanced Medical Equipment & Technology

	1st Jan change	Capi.
HANGZHOU AGS MEDTECH CO., LTD.	-32.11%	701M
THERMO FISHER SCIENTIFIC	+8.07%	219B
DANAHER CORPORATION	+7.87%	184B
INTUITIVE SURGICAL, INC.	+12.75%	138B
SIEMENS HEALTHINEERS AG	-1.37%	62.54B
SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.	+4.88%	52.22B
EDWARDS LIFESCIENCES CORPORATION	+11.59%	51.73B
AGILENT TECHNOLOGIES, INC.	+2.71%	41.4B
GE HEALTHCARE TECHNOLOGIES INC.	+4.90%	37.17B
RESMED, INC.	+23.75%	31.76B

Other Advanced Medical Equipment & Technology